Efficiency of specialist rehabilitation in reducing dependency and costs of continuing care for adults with complex acquired brain injuries.
L Turner-Stokes, S Paul, H Williams
https://pubmed.ncbi.nlm.nih.gov/16614023Actively Recruiting
Led by University College, London · Updated on 2024-10-23
75
Participants Needed
1
Research Sites
17 weeks
Total Duration
U
University College, London
Lead Sponsor
N
Nordoff and Robbins
Collaborating Sponsor
Researchers are studying whether adding music therapy to specialist rehabilitation programs improves functional recovery for patients with complex neurological injuries, including brain, spinal cord, or peripheral nerve damage. This randomized, blinded trial compares functional outcomes between patients receiving music therapy plus usual care and those receiving control therapy plus usual care. The goal is to assess if music therapy enhances recovery by supporting emotional, social, cognitive, and physical rehabilitation. Participants are assigned to either music therapy or control therapy groups, each receiving 15 hours of therapy over about 10 weeks, alongside usual neurorehabilitation. Music therapy involves individual and group sessions using the Nordoff Robbins approach, focusing on active music-making and improvisation to meet patient needs. Control therapy sessions match music therapy in duration and frequency but include activities like gaming, education, mindfulness, discussions, and stretching without specialized equipment. Participants undergo baseline and post-intervention assessments measuring functional independence, dependency, daily living activities, quality of life, psychological distress, social interaction, well-being, communication, pain, and mood. Assessments occur at baseline, during the 10-week intervention, and at its end. After intervention completion, all participants can access music therapy until discharge. Additional qualitative data will be gathered through interviews and observations during the rehabilitation stay.
CONDITIONS
MUSic Therapy In Complex Specialist Neurorehabilitation
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Approximately 10 weeks
Participants receive either Music Therapy or Control Therapy in addition to their usual intensive neurorehabilitation program. Therapy sessions occur weekly and include individual and group sessions tailored to support emotional, social, cognitive, and physical rehabilitation or usual care activities such as gaming and mindfulness. The intervention lasts until participants complete 15 hours of therapy, typically over approximately 10 weeks.
Weekly individual and group therapy sessions
Duration - Within 1 week post-intervention and up to discharge
After completing the therapy intervention, participants undergo reassessment of functional outcomes, quality of life, psychological distress, well-being, social interaction, and communication confidence. Additional optional interviews may be conducted before discharge to gather experiences related to music therapy.
1 to 2 assessment visits and optional interview
Total: 1 location
1
University College Hospitals NHS Foundation Trust
London, United Kingdom
Actively Recruiting
S
Sara Ajina
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
L Turner-Stokes, S Paul, H Williams
https://pubmed.ncbi.nlm.nih.gov/16614023L Turner-Stokes, K Nyein, D Halliwell
https://pubmed.ncbi.nlm.nih.gov/10392653Eckart Altenmüller, Gottfried Schlaug
https://pubmed.ncbi.nlm.nih.gov/25725918Gaël Le Perf, Anne-Lise Donguy, Guillaume Thebault
https://pubmed.ncbi.nlm.nih.gov/31170034Berit Marie Dykesteen Vik, Geir Olve Skeie, Karsten Specht
https://pubmed.ncbi.nlm.nih.gov/31293405